The evolution of long-acting antipsychotic treatments
- PMID: 39691770
- PMCID: PMC11650592
- DOI: 10.1177/20451253241305610
The evolution of long-acting antipsychotic treatments
Keywords: long-acting antipsychotic injectables; long-acting antipsychotic treatments.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Similar articles
-
Characteristics of people on long-acting injectable antipsychotics in Australia: Data from the 2010 National Survey of High Impact Psychosis.Aust N Z J Psychiatry. 2021 Oct;55(10):958-975. doi: 10.1177/00048674211009602. Epub 2021 Apr 27. Aust N Z J Psychiatry. 2021. PMID: 33906481
-
Systematic review of long-acting injectable antipsychotic medications approved from 2008 to october 2024 and agents in phase 3.Int J Psychiatry Med. 2024 Dec 19:912174241310091. doi: 10.1177/00912174241310091. Online ahead of print. Int J Psychiatry Med. 2024. PMID: 39703084 Review.
-
Antipsychotic utilisation and persistence in Australia: A nationwide 5-year study.Aust N Z J Psychiatry. 2022 Sep;56(9):1155-1163. doi: 10.1177/00048674211051618. Epub 2021 Oct 16. Aust N Z J Psychiatry. 2022. PMID: 34657454
-
Long-Acting Injectables: Current Perspectives and Future Promise.Crit Rev Ther Drug Carrier Syst. 2019;36(2):137-181. doi: 10.1615/CritRevTherDrugCarrierSyst.2018025649. Crit Rev Ther Drug Carrier Syst. 2019. PMID: 30806211 Review.
-
Lipid based intramuscular long-acting injectables: Current state of the art.Eur J Pharm Sci. 2022 Nov 1;178:106253. doi: 10.1016/j.ejps.2022.106253. Epub 2022 Jul 3. Eur J Pharm Sci. 2022. PMID: 35793750 Review.
References
-
- García-Carmona JA, García-Pérez A, Isidro García G, et al.. Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study. Ther Adv Psychopharmacol 2023; 13: 20451253231220907. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources